Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
항 바이러스 약물 테스트 및 유전자 기능 연구를위한 비 감염성 SARS-COV-2 레플리 콘의 구성
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Antiviral compounds
antiviral drug
antiviral drugs
antivirals
BAC
Bacterial
biosafety
biosafety level
Biosafety Level 3
BSL2
BSL3
catalytic site
catalytic sites
catastrophic
caused
chromosomal
construction
contribute
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
deleting
demonstrated
detect
DNA
dose-dependent manner
drug
Drug administration
effective vaccine
Effective vaccines
effort
expressing
food
function
functions
genetics
global public health
in viral
inhibited
level 2
level 3
nano luciferase
nLuc
nonstructural protein 15
nucleocapsid
nucleocapsid protein
outbreak
pandemic
performed
Plasmid
principle
proof
Protein
reduced
Remdesivir
Replication
replicon
reporter
respiratory
resulting
reverse genetics.
SARS-CoV-2
SARS-CoV-2 biology
SARS-CoV-2 protein
SARS-CoV-2 proteins
SARS-CoV-2 virus
severe acute respiratory syndrome Coronavirus
significantly
Spread
Testing
the SARS-CoV-2
transcript
transfecting
Vero E6
VERO E6 cells
Viral
viral pathogen
viral replication
Viral RNA
[DOI] 10.1128/JVI.00687-21 PMC 바로가기 [Article Type] Article
[DOI] 10.1128/JVI.00687-21 PMC 바로가기 [Article Type] Article